• Subscribe
  • Magazines
  • About
  • Contact
  • Advertise
Monday 4 August 2025
  • zh-hant 中文
  • ja 日本語
  • en English
IAG
Advertisement
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
  • 日本語
No Result
View All Result
IAG
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
  • 日本語
No Result
View All Result
IAG
No Result
View All Result

COVID-19 vaccine could be available by October after “world first” facility in Beijing granted production approval

Newsdesk by Newsdesk
Sun 9 Aug 2020 at 11:09
COVID-19 vaccine could be available by October after “world first” facility in Beijing granted production approval
327
SHARES
4.5k
VIEWS
Print Friendly, PDF & Email

China could make available the world’s first COVID-19 vaccine as early as October after the state-run China National Biotec Group (CNBG) announced that a vaccine production facility passed national examination.

According to a report in The Global Times, the facility, located in Beijing, was granted a production certificate following a recent thorough biosecurity examination, meaning it has now been approved to start large scale production once a COVID-19 vaccine is ready. It is described as the “first and largest of its kind” in the world and has the ability to produce 220 million doses of vaccine annually.

Experts now believe the first doses could be produced and made available as early as October give that a number of domestically made candidate vaccines have already entered Phase III trials.

Among them is a vaccine developed by Chinese pharmaceutical company Sinopharm, which is currently testing its candidate on 15,000 volunteers in the United Arab Emirates and preparing to launch a similar trial in Brazil.

Germany’s BioNTech, working in partnership with Shanghai Fosun Pharmaceutical, announced last week that it is has dosed 72 trial participants with a vaccine using mRNA technology – a method which prompts the human body to create its own infection-fighting medicine.

As reported extensively by Inside Asian Gaming last week, a team working out of the Faculty of Medicine at Macau University of Science and Technology (MUST), in collaboration with scientists from mainland China and Hong Kong, have made their own potentially game changing breakthrough, announcing that a vaccine developed using certain residues found in the Spike protein receptor-binding domain (S-RBD) – which is what the COVID-19 virus uses to engage with the cells of the host and cause infection – induced a “potent functional antibody response” in immunized mice, rabbits and monkeys.

These antibodies effectively blocked S-RBD from binding with the host cell receptor as it does in cases of infection, therefore neutralizing the virus during laboratory studies.

Any vaccine produced out of the newly approved Beijing facility would first be used locally, primarily on medical staff and those working at border checkpoints, however the timeline is notable given that most candidate vaccines have targeted early 2021 for release.

“It is possible that China could have a COVID-19 vaccine as early as the end of October as some domestically made COVID-19 vaccines have entered phase three clinical trials and need about a month to observe their effects on samples,” Shanghai-based vaccine researcher Tao Lina told The Global Times.

There are reportedly 13 Chinese companies currently working on the development of COVID-19 vaccines of which nine have been approved for clinical trials.

RelatedPosts

Singapore’s Changi Airport now Asia’s busiest airport as Hong Kong falls further behind

Singapore’s Changi Airport says passenger traffic from China up almost 16% in 2Q25

Wed 23 Jul 2025 at 05:55
Starr Xian: Human Factor

China’s GDP grows 5.3% in first half of 2025, in line with expectations

Tue 15 Jul 2025 at 12:30
Macau ranks first in China Tourism Academy’s “2024 Chinese Travellers Outbound Satisfaction Top 10 Destinations”

Macau ranks first in China Tourism Academy’s “2024 Chinese Travellers Outbound Satisfaction Top 10 Destinations”

Sun 29 Jun 2025 at 09:57
Falling Thailand visitor numbers linked to safety concerns as IR operators say it’s time to reboot tourism offering

Falling Thailand visitor numbers linked to safety concerns as IR operators say it’s time to reboot tourism offering

Thu 12 Jun 2025 at 16:40
Load More
Tags: ChinaChina National Biotec Groupcovid-19Faculty of Medicine at Macau University of Science and TechnologyProduction facilityThe Global TimesVaccination
Share218Share13
Newsdesk

Newsdesk

The IAG Newsdesk team comprises some of the most experienced journalists in the Asian gaming industry. Offering a broad range of expertise, their decades of combined know-how spans multiple countries across a variety of topics.

Current Issue

Editorial – Better late than never

Editorial – Better late than never

by Ben Blaschke
Thu 31 Jul 2025 at 07:13

Inside Asian Gaming has in recent weeks been hearing increasing chatter around a possible move by Vietnamese authorities to introduce...

Angel’s Yasushi Shigeta

Angel’s Yasushi Shigeta

by Ben Blaschke
Thu 31 Jul 2025 at 07:08

Yasushi Shigeta, Chairman and owner of one of the world’s largest gaming industry suppliers, Angel Group, sits down with Inside...

The Magic Number

The Magic Number

by David Bonnet
Thu 31 Jul 2025 at 06:41

In this in-depth deep dive into the evolution of the Asian gaming landscape, David Bonnet argues that many regional jurisdictions...

Rashid Suliman – A road well traveled

Rashid Suliman – A road well traveled

by Ben Blaschke
Thu 31 Jul 2025 at 02:45

Rashid Suliman, Vice President of Global Gaming Asia-Pacific for casino solutions provider TransAct Technologies, provides some insight into his unique...

Evolution Asia
Your browser does not support HTML5 video.
Aristocrat
GLI
Nustar
SABA
Mindslot
Solaire
Hann
Tecnet
HKUST
NWR

Related Posts

Legal battle continues to hurt Donaco’s bottom line

Donaco shareholders approve US$35 million privatization bid

by Ben Blaschke
Mon 4 Aug 2025 at 15:36

A proposal by Hong Kong’s Argyle Street Management Limited to acquire 100% of the shares in ASX-listed, Southeast Asian casino operator Donaco International Ltd that it doesn’t already own is one step away from becoming reality after Donaco shareholders on...

Light & Wonder’s Siobhan Lane

Global debut of “Fortune Doors” among five Light & Wonder game families to be showcased at next week’s Australasian Gaming Expo

by Ben Blaschke
Mon 4 Aug 2025 at 13:16

Global gaming giant Light & Wonder will debut its latest game family, Fortune Doors, at next week’s Australasian Gaming Expo in Sydney – one of five game families offering 14 unique themes between them to feature at the company’s stand....

Experts claim 90% of Macau money exchange gangs eradicated since passing of illegal gaming law

Morgan Stanley says Macau now a growth market, raising 2025 GGR and EBITDA forecasts after two consecutive monthly beats

by Ben Blaschke
Mon 4 Aug 2025 at 11:48

Investment bank Morgan Stanley has raised its Macau GGR and EBITDA growth forecasts for 2025, and operator price targets by 30% across the board, following two consecutive monthly beats in June and July. In a Monday note, Morgan Stanley analysts...

Hann Resorts founder Dae Sik Han says IPO essential to ensure no delays to Clark expansion plans

Hann Resorts founder Dae Sik Han says IPO essential to ensure no delays to Clark expansion plans

by Ben Blaschke
Mon 4 Aug 2025 at 06:02

The Chairman and CEO of Hann Philippines Inc, Dae Sik Han, has revealed he opted to proceed with an initial public offering on the Philippine Stock Exchange to ensure his ambitious expansion plans could proceed without delay. Hann, the parent...

Your browser does not support the video tag.


IAG

© 2005-2025
Inside Asian Gaming.
All rights reserved.

  • SUBSCRIBE FREE
  • NEWSFEED
  • MAG ARTICLES
  • VIDEO
  • OPINION
  • TAGS
  • REGIONAL
  • EVENTS
  • CONSULTING
  • CONTRIBUTORS
  • MAGAZINES
  • ABOUT
  • CONTACT
  • ADVERTISE
  • 中文
  • 日本語

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • 中文
  • 日本語
  • Subscribe
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
  • Events
  • Contributors
  • Magazines
  • Advertise
  • Contact
  • About
  • Home for G2E Asia

© 2005-2025
Inside Asian Gaming.
All rights reserved.

  • 中文
  • English
  • 日本語